The weight loss drug craze of the last couple of years brings important considerations for otolaryngologists, including how to manage gastric emptying before procedures for patients taking the medications and the possibility of the drugs being a new option for obstructive sleep apnea patients.
As with any powerful new technology, excitement over the real and potential benefits of LLMs within healthcare will need to be continually evaluated against real and potential risks. With the launch of ChatGPT for general usage, the time has arrived to weigh in on this balancing act as more people adopt the technology.
Global Group Reaches Consensus on Laryngopharyngeal Reflux Definition, Diagnostic Criteria
Identified risk factors for perioperative complications and long-term morbidity in infants included intraoperative cardiopulmonary arrest, postoperative cardiopulmonary death, and severe perioperative complications.
Nasolabial flap (NLF) achieved satisfactory results in secondary rhinoplasty of unilateral CLND for patients with nasal tissue deficiencies in whom the surgeon weighed the potential benefits over postoperative scarring.
If writers understand ChatGPT’s strengths and weaknesses, they can harness its power to make their processes more efficient and their products more robust, leveraging the tool to their advantage.
Targeted immunotherapies have become part of ATC treatment over the last decade or so, boosting recognition of tumor cells and activation of the immune system. But the studies on their effects have been fairly scarce and heterogeneous.
Daytime somnolence and sleep apnea are associated with dizziness in the elderly. New study shows that these conditions have an independent link to dizziness apart from the many overlapping comorbidities that are often seen in an older population
Over 44,000 Applicants and Nearly 6,400 Residency Programs Participate in Match Day 2024
The FDA recently expanded the approval of the XHANCE fluticasone propionate nasal spray manufactured by Optinose for chronic rhinosinusitis to also include treatment of adults aged 18 and older without nasal polyps.